scholarly journals Correlation between Isotherms and Isodoses in Breast Cancer Radiotherapy—First Study

2021 ◽  
Vol 18 (2) ◽  
pp. 619
Author(s):  
Dominika Plaza ◽  
Agnieszka Baic ◽  
Barbara Lange ◽  
Agata Stanek ◽  
Krzysztof Ślosarek ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Treatment Planning ◽  
Treatment Plan ◽  
The Body ◽  
Planning System ◽  
Treatment Planning System ◽  
Breast Cancer Radiotherapy ◽  
The Mean ◽  
Radiotherapy Treatment ◽  
Tumor Area

The study is focused on correlation of isotherms derived from thermal images with an isodoses describing treatment plan for patients with breast cancer treated by radiotherapy. The irradiated area covered the part of the body after mastectomy. The study included patients diagnosed with breast cancer who were qualified for radiotherapy treatment. All patients were monitored during each treatment week during the entire radiotherapy process. The measurements were made under strictly defined conditions. In the treatment planning system (TPS), the specific plan was created for each patient. Spatial dose distribution in the patient’s body was obtained and presented by the isodoses (lines connecting points with the same dose values). The following areas from the treatment planning system were plotted on the thermograms: target (tumor area) and isodose: 45 Gy, 40 Gy, 30 Gy, 20 Gy and 10 Gy. The obtained results indicated a high correlation between magnitude of the dose represented as the isodose and the temperature of the treated skin. Moreover, preliminary analysis showed a repeatable increase of the mean temperature in the irradiated area during the treatment.

Utilising virtual bolus in superficial planning target volume dose optimisation (TomoTherapy): a phantom study

2019 ◽  
Vol 19 (1) ◽  
pp. 65-70
Author(s):  
Gim Chee Ooi ◽  
Iskandar Shahrim Bin Mustafa
Keyword(s):  
Treatment Planning ◽  
Planning Target Volume ◽  
Treatment Plan ◽  
Target Volume ◽  
The Body ◽  
Phantom Study ◽  
Planning System ◽  
Treatment Planning System ◽  
Dose Volume Histograms ◽  
Photon Fluence

AbstractAim:This is a phantom study to evaluate the dosimetry effects of using virtual bolus (VB) in TomoTherapy Treatment Planning System (TPS) optimisation for superficial planning target volume (PTV) that extends to the body surface. Without VB, the inverse-planning TPS will continuously boost the photon fluence at the surface of the superficial PTV due to lack of build-up region. VB is used during TPS optimisation only and will not be present in actual treatment delivery.Materials and methods:In this study, a dummy planning target was contoured on a cylindrical phantom which extends to the phantom surface, and VB of various combinations of thickness and density was used in treatment planning optimisation with TomoTherapy TPS. The plans were then delivered with the treatment modality TomoTherapy. Radiochromic films (Gafchromic EBT3) were calibrated and used for dose profiles measurements. TomoTherapy Planned-Adaptive software was used to analyse the delivered Dose-Volume Histograms (DVHs).Results:The use of 2 mm VB was not providing adequate build-up area and was unable to reduce the hot spots during treatment planning and actual delivery. The use of 4 mm VB was able to negate the photon fluence boosting effect by the TPS, and the actual delivery showed relatively small deviations from the treatment plan. The use of 6 mm VB caused significant dose overestimation by the TPS in the superficial regions resulting in insufficient dose coverage delivered.Findings:VB with the combination of 4 mm thickness and 1·0 g/cc density provides the most robust solution for the TomoTherapy TPS optimisation of superficial PTV.

PH-0163: Harmonization of breast cancer radiotherapy treatment planning in the Netherlands

2020 ◽  
Vol 152 ◽  
pp. S77-S78
Author(s):  
M. Verhoeven ◽  
M. Sangen van der ◽  
C. Hurkmans ◽  
L. Boersma ◽  
K. Verhoeven ◽  
...  
Keyword(s):  
Breast Cancer ◽  
The Netherlands ◽  
Treatment Planning ◽  
Radiotherapy Treatment Planning ◽  
Cancer Radiotherapy ◽  
Breast Cancer Radiotherapy ◽  
Radiotherapy Treatment

scholarly journals Treatment planning comparison of volumetric modulated arc therapy with Trilogy and Halcyon for bilateral breast cancer

2021 ◽  
Author(s):  
Tao Sun ◽  
Xiutong Lin ◽  
Guifang Zhang ◽  
Qingtao Qiu ◽  
Chengqiang Li ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Treatment Planning ◽  
Volumetric Modulated Arc Therapy ◽  
Bilateral Breast Cancer ◽  
Planning System ◽  
Skin Dose ◽  
Delivery Time ◽  
Dose Volume ◽  
Arc Therapy ◽  
The Mean

Abstract Background: The Halcyon is a new machine from the Varian company. The purpose of this study was to evaluate the dosimetry of the Halcyon in treatment of bilateral breast cancer with volumetric modulated arc therapy. Methods: On CT images of 10 patients with bilateral breast cancer, four Halcyon plans with different setup fields were generated, and dosimetric comparisons using Bonferroni’s multiple comparisons test were conducted among the four plans. Whole and partial arc plans on the Trilogy and the Halcyon, referred to as T-4arc, T-8arc, H-4arc and H-8arc, were designed. The prescription dose was 50 Gy in 2-Gy fractions. All plans were designed with the Eclipse version 15.5 treatment planning system. The dosimetric differences between whole and partial arc plans in the same accelerator were compared using the Mann-Whitney U test. The better Halcyon plan was selected for the further dosimetric comparison of the plan quality and delivery efficiency between the Trilogy and the Halcyon. Results:Halcyon plans with high‐quality megavoltage cone beam CT setup fields increased the Dmean, D2 and V107 of the planning target volume (PTV) and the V5 and Dmean of the heart, left ventricle (LV) and lungs compared with other Halcyon setup plans. The mean dose and low dose volume of the heart, lungs and liver were significantly decreased in T-8arc plans compared to T-4arc plans. In terms of the V5, V20, V30, V40 and Dmean of the heart, the V20, V30, V40 and Dmean of the LV, the V30, V40, Dmax and Dmean of the left anterior descending artery (LAD), and the V5 and V40 of lungs, H-8arc was significantly higher than H-4arc (p<0.05). Compared with the Trilogy’s plans, the Halcyon’s plans reduced the high-dose volume of the heart and LV but increased the mean dose of the heart. For the dose of the LAD and the V20 and V30 of lungs, there was no significant difference between the two accelerators. Compared with the Trilogy, plans on the Halcyon significantly increased the skin dose but also significantly reduced the delivery time. Conclusion: For the Halcyon, the whole-arc plans have more dosimetric advantages than partial-arc plans in bilateral breast cancer radiotherapy. Although the mean dose of the heart and the skin dose are increased, the doses of the cardiac substructure and other OARs are comparable to the Trilogy, and the delivery time is significantly reduced.

Dose assessment to the Bladder during Intracavitary Brachytherapy of the Cervix using Gafchromic films

2017 ◽  
pp. 97-105
Author(s):  
J. Avevor ◽  
S. N. A. Tagoe ◽  
J. H. Amuasi ◽  
J. J. Fletcher ◽  
I. Shirazu
Keyword(s):  
Treatment Planning ◽  
Maximum Dose ◽  
Mean Difference ◽  
Planning System ◽  
Treatment Planning System ◽  
In Vivo Dosimetry ◽  
Intracavitary Brachytherapy ◽  
Gafchromic Films ◽  
System Verification ◽  
The Mean

Intracavitary brachytherapy procedures are used for cervical cancer treatment, by the insertion of radioactive implants directly into the diseased tissues. During the treatment process, the bladder together with surrounding tissues are exposed to radiations. Clinical complications do results from high doses received by parts of the bladder during intracavitary brachytherapy of the cervix. The aim of this study is to assess the dose delivered to the bladder using Gafchromic films and compare it with the optimized dose calculated by the Brachy Prowess 4.60 Treatment Planning System (TPS) reports for empirical validation and system verification. Fletcher suite applicators were used to perform thirty (30) different clinical insertions on the constructed cervix phantom and results evaluated. The mean difference between the doses calculated by the TPS and the doses measured by the Gafchromic film for the bladder at the distance of 0.5cm from the edge of the film was 16.3 % (range -35.33 to +39.37). At a distance of 1.5cm for the bladder, the mean difference was 19.4% (range -49.48 to +30.39). The TPS calculated maximum dose was typically higher than the measured maximum dose. However, in some cases, the measured doses were found to be higher than the doses calculated by the TPS. This is due to positional inaccuracies of the sources during treatment planning. It is recommended that in vivo dosimetry be performed in addition to computation.

Sign in / Sign up

Export Citation Format

Share Document